跳至主要内容
临床试验/NCT05806996
NCT05806996已完成2 期

Magnesium and Bladder Spasms Following Ambulatory Urologic Procedures

Mayo Clinic3 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2023年6月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
Mayo Clinic
入组人数
120
试验地点
3
主要终点
Incidence of bladder spasm

研究概览

简要总结

This research is being done to find out whether intravenous magnesium is effective in the treatment of bladder spasms after urologic surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - Be undergoing a bladder invasive procedure with or without planned urinary catheter on Mayo Clinic Gonda 7 Outpatient Procedure Center.

排除标准

  • Are unable to grant informed consent or comply with study procedure.
  • Allergy or known sensitivity to magnesium or Renacidin.
  • Expected or high risk of bladder extravasation.
  • Ongoing atrial fibrillation prior to surgery.
  • Are undergoing emergency surgery.
  • Are pregnant.
  • Known hypermagnesemia.
  • Patients with neuromuscular weakness (e.g., Myasthenia gravis) due to magnesium's muscle weakening effect.
  • Patients with myocardial compromise or cardiac conduction defects because of magnesium's anti-inotropic effects.
  • Patients with renal insufficiency, glomerular filtration rate less than 30, since Magnesium is eliminated by the kidneys resulting in exaggerated rise in serum magnesium.
  • Patients with concomitant use of a calcium channel blocker since magnesium sulfate could act synergistically to suppress muscular contractility.

研究组 & 干预措施

Placebo Group

Placebo Comparator

Subjects having urology surgery per standard of care will receive intravenous placebo during the surgery.

干预措施: Placebo (Drug)

Magnesium Group

Experimental

Subjects having urology surgery per standard of care will receive intravenous magnesium during the surgery.

干预措施: Magnesium (Drug)

结局指标

主要结局

Incidence of bladder spasm

时间窗: Post-operative, approximately 1 hour

Number of subjects to experience bladder spasms

次要结局

  • Incidence of bladder spasm above moderate grade(Post-operative, approximately 4 hours)
  • Treatment for bladder spasms(Post-operative, approximately 4 hours)
  • Patient satisfaction(Post-operative, approximately 4 hours)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gregory A Nuttall

Principal Investigator

Mayo Clinic

研究点 (3)

Loading locations...

相似试验